15th July 2015
Exosect receives US approval to import first biological control agent for insect control in grain
Winchester, UK – Exosect Ltd., a leading provider of enabling technologies, has announced that it has received approval to import it’s isolate of the entomopathogenic fungus, Beauveria bassiana, into the USA to further the development programme of the formulation for the control of insect pests in grain and stored commodities.
Exosect has, over the past nine years, been developing this biological formulation for grain and stored commodities as part of a European development programme, using its proprietary platform technology, Entostat.
Entostat, a patented electrostatic micro-powder, delivers biological and synthetic ingredients. For this biological formulation, Entostat delivers an optimised formulation of fungal spores. In this programme it has been developed as a formulation for the structural treatment of grain silos. A further formulation development programme is currently underway for application of this biological control agent as an admixture. A data package for this particular isolate of Beauveria bassiana is now under review with European regulators and is due to be approved in 2017.
Exosect’s Managing Director, Martin Brown comments “For the grain and commodity storage sector, the development of a biological formulation for the control of insects post-harvest will be encouraging news due to the limited number of active ingredients currently available and the need for more tools for Integrated Pest Management. This development programme complements recent trials in grain where Entostat successfully delivered deltamethrin and pirimyphos-methyl both separately and in co-formulation, at rates half that of conventional formulations”.
The import approval has been sought in the US to enable in country development. Exosect are currently seeking license partners for this technology and further country import approvals are expected in due course.
- Ends -
Notes to Editors
For further information please contact: Georgina Donovan at Exosect.
Tel: 02380 603939 or email: email@example.com